Thrombin Generation Parameters and Bleeding in Patients Treated With Anticoagulants for Cancer Associated Thrombosis
Thrombin Generation Parameters and Bleeding in Patients Treated With Anticoagulants for Cancer Associated Thrombosis
Recruiting · NCT06386107 · Registry updated 2026-08-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Thrombin Generation Parameters and Bleeding in Patients Treated With Anticoagulants for Cancer Associated Thrombosis | Embolism, Embolism and Thrombosis, cancer, cardiovascular disorder, lung disorder, neoplasm, pulmonary embolism, respiratory system disorder, thrombotic disease, vascular disorder | Recruiting | Not applicable | 2026-08-24 | NCT06386107 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Centre Hospitalier Universitaire de Saint Etienne | 129 |
| Diagnostica Stago | 2 |
| LEO Pharma | 16 |
| Ligue contre le cancer, France | 19 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| CHU Clermont-Ferrand | Clermont-Ferrand | France | 19 |
| CHU de Grenoble | Grenoble | France | 22 |
| Chu St-Etienne | Saint-Etienne | France | 1 |
| HCL | Lyon | France | 13 |